United Therapeutics Corporation (UTHR)
USD 279.69
(-4.12%)
USD 279.69
(-4.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.32 Billion USD | 20.2% |
| 2022 | 1.93 Billion USD | 14.88% |
| 2021 | 1.68 Billion USD | 13.63% |
| 2020 | 1.48 Billion USD | 2.38% |
| 2019 | 1.44 Billion USD | -11.0% |
| 2018 | 1.62 Billion USD | -5.65% |
| 2017 | 1.72 Billion USD | 7.91% |
| 2016 | 1.59 Billion USD | 9.08% |
| 2015 | 1.46 Billion USD | 13.76% |
| 2014 | 1.28 Billion USD | 15.36% |
| 2013 | 1.11 Billion USD | 21.93% |
| 2012 | 916.07 Million USD | 23.26% |
| 2011 | 743.18 Million USD | 23.08% |
| 2010 | 603.83 Million USD | 63.26% |
| 2009 | 369.84 Million USD | 31.39% |
| 2008 | 281.49 Million USD | 33.45% |
| 2007 | 210.94 Million USD | 32.14% |
| 2006 | 159.63 Million USD | 37.71% |
| 2005 | 115.91 Million USD | 57.51% |
| 2004 | 73.59 Million USD | 37.96% |
| 2003 | 53.34 Million USD | 77.09% |
| 2002 | 30.12 Million USD | 425.5% |
| 2001 | 5.73 Million USD | 179.7% |
| 2000 | 2.04 Million USD | 412.31% |
| 1999 | 400 Thousand USD | 300.0% |
| 1998 | 100 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 748.9 Million USD | 4.76% |
| 2024 Q2 | 714.9 Million USD | 5.49% |
| 2024 Q1 | 677.7 Million USD | 10.25% |
| 2023 Q2 | 596.5 Million USD | 17.68% |
| 2023 Q3 | 609.4 Million USD | 2.16% |
| 2023 Q4 | 614.7 Million USD | 0.87% |
| 2023 FY | 2.32 Billion USD | 20.2% |
| 2023 Q1 | 506.9 Million USD | 3.13% |
| 2022 Q1 | 461.9 Million USD | 11.25% |
| 2022 FY | 1.93 Billion USD | 14.88% |
| 2022 Q4 | 491.5 Million USD | -4.75% |
| 2022 Q3 | 516 Million USD | 10.52% |
| 2022 Q2 | 466.9 Million USD | 1.08% |
| 2021 Q4 | 415.2 Million USD | -6.63% |
| 2021 Q2 | 446.5 Million USD | 17.78% |
| 2021 FY | 1.68 Billion USD | 13.63% |
| 2021 Q3 | 444.7 Million USD | -0.4% |
| 2021 Q1 | 379.1 Million USD | -1.51% |
| 2020 Q2 | 362 Million USD | 1.6% |
| 2020 Q4 | 384.9 Million USD | 1.26% |
| 2020 Q3 | 380.1 Million USD | 5.0% |
| 2020 FY | 1.48 Billion USD | 2.38% |
| 2020 Q1 | 356.3 Million USD | 14.53% |
| 2019 Q1 | 362.6 Million USD | -4.93% |
| 2019 FY | 1.44 Billion USD | -11.0% |
| 2019 Q2 | 373.6 Million USD | 3.03% |
| 2019 Q3 | 401.5 Million USD | 7.47% |
| 2019 Q4 | 311.1 Million USD | -22.52% |
| 2018 Q3 | 412.7 Million USD | -7.15% |
| 2018 FY | 1.62 Billion USD | -5.65% |
| 2018 Q1 | 389.2 Million USD | -16.25% |
| 2018 Q2 | 444.5 Million USD | 14.21% |
| 2018 Q4 | 381.4 Million USD | -7.58% |
| 2017 Q2 | 444.6 Million USD | 20.0% |
| 2017 Q4 | 464.7 Million USD | 4.31% |
| 2017 FY | 1.72 Billion USD | 7.91% |
| 2017 Q1 | 370.5 Million USD | -9.41% |
| 2017 Q3 | 445.5 Million USD | 0.2% |
| 2016 Q4 | 409 Million USD | 0.2% |
| 2016 Q2 | 412.6 Million USD | 11.82% |
| 2016 Q1 | 369 Million USD | -8.86% |
| 2016 FY | 1.59 Billion USD | 9.08% |
| 2016 Q3 | 408.2 Million USD | -1.07% |
| 2015 Q3 | 386.22 Million USD | 11.25% |
| 2015 FY | 1.46 Billion USD | 13.76% |
| 2015 Q4 | 404.87 Million USD | 4.83% |
| 2015 Q2 | 347.16 Million USD | 6.0% |
| 2015 Q1 | 327.5 Million USD | -5.44% |
| 2014 Q1 | 289.4 Million USD | 0.13% |
| 2014 Q3 | 329.95 Million USD | 2.21% |
| 2014 Q4 | 346.36 Million USD | 4.97% |
| 2014 Q2 | 322.8 Million USD | 11.54% |
| 2014 FY | 1.28 Billion USD | 15.36% |
| 2013 Q1 | 245.13 Million USD | 0.54% |
| 2013 FY | 1.11 Billion USD | 21.93% |
| 2013 Q4 | 289.01 Million USD | -4.37% |
| 2013 Q3 | 302.22 Million USD | 7.7% |
| 2013 Q2 | 280.6 Million USD | 14.47% |
| 2012 FY | 916.07 Million USD | 23.26% |
| 2012 Q3 | 242.46 Million USD | 7.49% |
| 2012 Q1 | 204.21 Million USD | 4.63% |
| 2012 Q4 | 243.81 Million USD | 0.56% |
| 2012 Q2 | 225.57 Million USD | 10.46% |
| 2011 Q4 | 195.17 Million USD | -3.25% |
| 2011 Q2 | 183.75 Million USD | 10.95% |
| 2011 Q3 | 201.74 Million USD | 9.79% |
| 2011 FY | 743.18 Million USD | 23.08% |
| 2011 Q1 | 165.61 Million USD | -0.52% |
| 2010 Q2 | 137.49 Million USD | 6.68% |
| 2010 Q1 | 128.88 Million USD | 18.32% |
| 2010 Q3 | 170.98 Million USD | 24.36% |
| 2010 Q4 | 166.47 Million USD | -2.64% |
| 2010 FY | 603.83 Million USD | 63.26% |
| 2009 FY | 369.84 Million USD | 31.39% |
| 2009 Q4 | 108.92 Million USD | 12.04% |
| 2009 Q3 | 97.21 Million USD | 15.76% |
| 2009 Q2 | 83.98 Million USD | 5.33% |
| 2009 Q1 | 79.73 Million USD | 5.1% |
| 2008 Q2 | 68.55 Million USD | 10.49% |
| 2008 Q3 | 75.03 Million USD | 9.45% |
| 2008 Q4 | 75.86 Million USD | 1.11% |
| 2008 FY | 281.49 Million USD | 33.45% |
| 2008 Q1 | 62.04 Million USD | 3.59% |
| 2007 Q2 | 51.83 Million USD | 29.03% |
| 2007 Q4 | 59.89 Million USD | 1.44% |
| 2007 Q3 | 59.04 Million USD | 13.92% |
| 2007 Q1 | 40.16 Million USD | -12.34% |
| 2007 FY | 210.94 Million USD | 32.14% |
| 2006 Q3 | 40.39 Million USD | 0.38% |
| 2006 Q4 | 45.82 Million USD | 13.44% |
| 2006 FY | 159.63 Million USD | 37.71% |
| 2006 Q1 | 33.16 Million USD | 11.89% |
| 2006 Q2 | 40.24 Million USD | 21.35% |
| 2005 Q3 | 33.01 Million USD | 9.82% |
| 2005 FY | 115.91 Million USD | 57.51% |
| 2005 Q1 | 23.2 Million USD | 7.38% |
| 2005 Q2 | 30.05 Million USD | 29.52% |
| 2005 Q4 | 29.64 Million USD | -10.21% |
| 2004 FY | 73.59 Million USD | 37.96% |
| 2004 Q4 | 21.61 Million USD | 8.09% |
| 2004 Q3 | 19.99 Million USD | 9.27% |
| 2004 Q2 | 18.29 Million USD | 33.74% |
| 2004 Q1 | 13.68 Million USD | 0.68% |
| 2003 FY | 53.34 Million USD | 77.09% |
| 2003 Q4 | 13.59 Million USD | -9.61% |
| 2003 Q3 | 15.03 Million USD | 7.57% |
| 2003 Q2 | 13.97 Million USD | 30.15% |
| 2003 Q1 | 10.73 Million USD | -10.67% |
| 2002 Q2 | 11.56 Million USD | 722.48% |
| 2002 FY | 30.12 Million USD | 425.5% |
| 2002 Q4 | 12.02 Million USD | 134.44% |
| 2002 Q3 | 5.12 Million USD | -55.66% |
| 2002 Q1 | 1.4 Million USD | -13.18% |
| 2001 Q3 | 1.31 Million USD | 0.14% |
| 2001 Q2 | 1.31 Million USD | -11.37% |
| 2001 FY | 5.73 Million USD | 179.7% |
| 2001 Q1 | 1.48 Million USD | 87.74% |
| 2001 Q4 | 1.61 Million USD | 23.07% |
| 2000 Q3 | 403.89 Thousand USD | -26.07% |
| 2000 Q4 | 789.66 Thousand USD | 95.51% |
| 2000 FY | 2.04 Million USD | 412.31% |
| 2000 Q1 | 309.39 Thousand USD | 54.7% |
| 2000 Q2 | 546.3 Thousand USD | 76.57% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1999 FY | 400 Thousand USD | 300.0% |
| 1999 Q4 | 200 Thousand USD | 100.0% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | 0.0% |
| 1998 FY | 100 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 194.62 Million USD | -1095.902% |
| Jaguar Health, Inc. | 9.76 Million USD | -23744.893% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -1541290.728% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | -27.305% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -1672.469% |
| ContextLogic Inc. | 287 Million USD | -710.976% |
| MiMedx Group, Inc. | 321.47 Million USD | -624.002% |
| MEI Pharma, Inc. | 65.29 Million USD | -3464.482% |
| AlloVir, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 983.7 Million USD | -136.605% |
| Aptorum Group Limited | 431.37 Thousand USD | -539450.0% |
| Ardelyx, Inc. | 124.45 Million USD | -1770.139% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -866.831% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -37289.558% |
| Pharming Group N.V. | 245.31 Million USD | -848.776% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -341175.66% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -5336.814% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -1891.325% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -24246.234% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 26.97 Million USD | -8528.04% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -1220.702% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -149674.775% |
| Acelyrin, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -90782.468% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -26409.112% |
| AbCellera Biologics Inc. | 38.02 Million USD | -6020.973% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -46549900.0% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -168559.42% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -1704.082% |
| Chimerix, Inc. | 324 Thousand USD | -718264.198% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -218650.0% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.66 Billion USD | -39.924% |
| Fortress Biotech, Inc. | 84.51 Million USD | -2654.014% |
| Fortress Biotech, Inc. | 84.51 Million USD | -2654.014% |
| Agenus Inc. | 156.31 Million USD | -1388.99% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -11462.919% |
| Dyadic International, Inc. | 2.89 Million USD | -80191.679% |
| ImmuCell Corporation | 17.47 Million USD | -13221.566% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -7255.73% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -9852.961% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 37.021% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -28695.002% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -893374.088% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -23324.919% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -290111.97% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -3603.91% |
| NextCure, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -12118.489% |
| Onconetix, Inc. | 58.46 Thousand USD | -3980914.282% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -296396.815% |
| Opthea Limited | 261.85 Thousand USD | -888737.122% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -69794.895% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| Seer, Inc. | 15.18 Million USD | -15230.655% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -28194.432% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -548838.679% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -1954.19% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -1319.952% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -11113.625% |
| ChromaDex Corporation | 83.57 Million USD | -2685.09% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -19223.371% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -6650.877% |
| CRISPR Therapeutics AG | 371.2 Million USD | -527.01% |
| Precision BioSciences, Inc. | 48.72 Million USD | -4676.613% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -3563.45% |
| Innoviva, Inc. | 310.46 Million USD | -649.687% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -45323.497% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -9456.952% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -23274900.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -129205.556% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -484.499% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -84229.71% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -277194.936% |
| Century Therapeutics, Inc. | 2.23 Million USD | -104038.702% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -10957.532% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -2199.583% |
| Autolus Therapeutics plc | 1.69 Million USD | -136973.027% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -4957.803% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -3422694.118% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -1266.898% |
| GRI Bio, Inc. | 21.76 Million USD | -10592.792% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -91534.363% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -109172.3% |
| INmune Bio, Inc. | 155 Thousand USD | -1501512.903% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -1732.042% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -103853.075% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -232650.0% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -27049.189% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -804.783% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -66400.0% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -147210.127% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -29862.667% |
| Histogen Inc. | 3.76 Million USD | -61653.781% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -398970.008% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -2135221.101% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -594112.334% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -6770.037% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -33863.228% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -1375.455% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1596264.883% |
| Apollomics, Inc. | 821 Thousand USD | -283395.737% |
| Amarin Corporation plc | 306.91 Million USD | -658.363% |
| Mesoblast Limited | 5.9 Million USD | -39335.784% |
| Turnstone Biologics Corp. | 19.3 Million USD | -11955.838% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -2861.497% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -1226.113% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | -27.171% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -2923.238% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -486.877% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -174768.52% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -1563.558% |
| Insmed Incorporated | 305.2 Million USD | -662.595% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -12355.849% |
| OmniAb, Inc. | 34.16 Million USD | -6712.727% |
| Alector, Inc. | 97.06 Million USD | -2297.952% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -1742.47% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -2259608.738% |
| Zai Lab Limited | 266.71 Million USD | -772.641% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -894.488% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1790284.615% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -13240.402% |
| Veracyte, Inc. | 361.05 Million USD | -544.646% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -50522.807% |
| FibroGen, Inc. | 147.75 Million USD | -1475.275% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -1574609.922% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 39.296% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -554066.667% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -511.236% |
| TG Therapeutics, Inc. | 233.66 Million USD | -896.097% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 25.137% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -149290.244% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -6714.522% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -2644.079% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -3953.183% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -435.983% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -5100.42% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -602.298% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -4217913.773% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -8850.546% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -25861011.111% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -70193.159% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 82.256% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -1905937.081% |
| Pluri Inc. | 326 Thousand USD | -713857.055% |
| Prothena Corporation plc | 91.37 Million USD | -2447.335% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -3761.084% |
| Celularity Inc. | 22.77 Million USD | -10121.334% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -42295.264% |
| MeiraGTx Holdings plc | 14.01 Million USD | -16504.837% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -833.135% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -3542.125% |
| Blueprint Medicines Corporation | 249.38 Million USD | -833.315% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -7410.73% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -31792.299% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -6316.265% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -46490.506% |
| Cytokinetics, Incorporated | 7.53 Million USD | -30809.695% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -111513.886% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -1765.059% |
| Evogene Ltd. | 5.64 Million USD | -41167.73% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -23191.304% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -24918.811% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -48389.583% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -6271.999% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -741142.038% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -116275.0% |
| MediciNova, Inc. | 1 Million USD | -232650.0% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -95016.469% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -13638927.249% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -760.126% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -148.181% |
| Mereo BioPharma Group plc | 10 Million USD | -23175.0% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -40604.792% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -11131.482% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -761.211% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -82876.827% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -382.508% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -2449900.0% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -48817.612% |
| Kezar Life Sciences, Inc. | 7 Million USD | -33150.0% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -11000.248% |
| aTyr Pharma, Inc. | 353 Thousand USD | -659248.442% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -14888.087% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -741142.038% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -19300837.059% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -180.674% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -1028820.286% |
| UroGen Pharma Ltd. | 82.71 Million USD | -2713.947% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -1414.008% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -8417621.519% |
| Orgenesis Inc. | 530 Thousand USD | -439050.943% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -1282.635% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -917781.636% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -1108.212% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -1028820.286% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -13638927.249% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -154756.953% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -44618.724% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -21138.252% |
| scPharmaceuticals Inc. | 13.59 Million USD | -17022.784% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -23121.59% |
| Daré Bioscience, Inc. | 2.8 Million USD | -82791.571% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -1264845.652% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 5.339% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -19999.309% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -3779.167% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -7790.633% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 3.792% |
| DBV Technologies S.A. | 15.72 Million USD | -14698.449% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 66.012% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -28971.946% |
| Molecular Templates, Inc. | 57.3 Million USD | -3961.529% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -1502.542% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -22969.68% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -33715.197% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -3861.77% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -360654.275% |
| Adagene Inc. | 18.11 Million USD | -12750.957% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -215010.906% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -705.517% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -830.97% |
| SciSparc Ltd. | 2.87 Million USD | -80744.043% |
| Vericel Corporation | 197.51 Million USD | -1078.386% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -39322.425% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -3804.808% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -9011.015% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -2306.058% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -2218.527% |
| ADMA Biologics, Inc. | 258.21 Million USD | -801.381% |
| Clene Inc. | 654 Thousand USD | -355786.85% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -9144.157% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -5121.537% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -4555.0% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -2175133.645% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -2600.743% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -3183371.933% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -3882.513% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -19695.033% |
| Trevena, Inc. | 3.12 Million USD | -74380.0% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -220.399% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -36914.949% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -29451.803% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -374096.141% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -42669.202% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -3218.221% |
| Celularity Inc. | 22.77 Million USD | -10121.334% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -57899.003% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -1487890.589% |
| Cibus, Inc. | 1.81 Million USD | -127995.762% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -64552.778% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -32393.369% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -120871.933% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -195.5% |
| Eyenovia, Inc. | 3787.00 USD | -61460158.78% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -887.748% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -2009.791% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -476846.721% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2838.614% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -257068.396% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -981967.511% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -34284.695% |
| Royalty Pharma plc | 2.35 Billion USD | 1.149% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -317053.832% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -6215.29% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -1369017.647% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -193213.953% |
| Notable Labs, Ltd. | 310 Thousand USD | -750706.452% |
| Liquidia Corporation | 17.48 Million USD | -13209.126% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -215010.906% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -12730.053% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -124900.0% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -135804.87% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -3227965.796% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -48817.612% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -7758233.333% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -14591.031% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -3497.206% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -546261.502% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -482.813% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -6856.275% |
| Peak Bio, Inc. | 367.87 Thousand USD | -632584.294% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -8375.656% |
| Benitec Biopharma Inc. | 216 Thousand USD | -1077446.296% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -262597.517% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -89.796% |
| Immunome, Inc. | 14.01 Million USD | -16503.652% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -140364.695% |
| CervoMed Inc. | 7.14 Million USD | -32475.811% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -47274.313% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -82260.226% |
| Moolec Science SA | 905.04 Thousand USD | -257068.396% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -279644.234% |
| AnaptysBio, Inc. | 17.15 Million USD | -13465.891% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -94511.937% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -105551.384% |
| Lumos Pharma, Inc. | 2.05 Million USD | -113381.229% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -5615.137% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -111513.886% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -1140831.373% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -1939483.333% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -930900.0% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -516.215% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -1148.833% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -5718.75% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -195652.733% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -14963.75% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -408233.333% |
| HCW Biologics Inc. | 2.84 Million USD | -81802.488% |
| XOMA Corporation | 4.75 Million USD | -48817.612% |
| Nektar Therapeutics | 90.12 Million USD | -2482.61% |
| Arvinas, Inc. | 78.5 Million USD | -2864.968% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -5196.152% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -75126.244% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -355786.85% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -132824.043% |
| Synlogic, Inc. | 3.37 Million USD | -68944.794% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -632584.294% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -11570.762% |
| Krystal Biotech, Inc. | 50.69 Million USD | -4490.82% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -1493.818% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -42629.943% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -517562.811% |
| MannKind Corporation | 198.96 Million USD | -1069.821% |
| Ikena Oncology, Inc. | 9.16 Million USD | -25309.389% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -1951.565% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -716.257% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -58187400.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -4540.614% |
| REGENXBIO Inc. | 90.24 Million USD | -2479.176% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -104247.865% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -31442.214% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -308178.146% |
| Longeveron Inc. | 709 Thousand USD | -328179.267% |
| Repare Therapeutics Inc. | 51.13 Million USD | -4451.855% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -87.198% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -19999.309% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -1108233.333% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 76.417% |
| Denali Therapeutics Inc. | 330.53 Million USD | -604.17% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -14181.806% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -86008.028% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -2906.018% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -1526830.394% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -15500.912% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -344714.815% |
| OmniAb, Inc. | 34.16 Million USD | -6712.727% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -10851.91% |
| Lipocine Inc. | -2.85 Million USD | 81743.234% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -103853.075% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -2720.836% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -2592.152% |
| Ocugen, Inc. | 6.03 Million USD | -38460.305% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -201240.83% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -6350.227% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -38677.41% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -367534.283% |
| Dominari Holdings Inc. | 2.03 Million USD | -114049.093% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -100.809% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -8577.255% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -299.899% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -18379.555% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -487845.493% |
| Iterum Therapeutics plc | - USD | -Infinity% |